MRC1 and neoplasm: Our studies with Nos2 and CD206 gene markers suggest, first, that both control and IMS-TMZ-treated tumours contain M1 and M2 microglia/macrophages (Figure 3A,B), in line with data for control GL261 tumours described in [66].